Clinical Trials Browser

Phase 1/2 × FED × 90 days × Clear all

NCT06681220 2026-03-11

Relapsed SCLC

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05842174 2026-01-22

TAQE

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular